Art
J-GLOBAL ID:200902298026055602   Reference number:09A0030124

The Efficacy of Reboxetine as an Antidepressant, a Meta-analysis of Both Continuous (Mean HAM-D Score) and Dichotomous (Response Rate) Outcomes

抗うつ剤としてのレボキセチンの有効性,連続(平均HAM-Dスコア)アウトカムと二値(奏効率)アウトカムのメタ分析
Author (4):
Material:
Volume: 54  Issue:Page: E147-E158 (WEB ONLY)  Publication year: 2008 
JST Material Number: U0095A  ISSN: 1883-0498  Document type: Article
Article type: 原著論文  Country of issue: Japan (JPN)  Language: ENGLISH (EN)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=09A0030124&from=J-GLOBAL&jstjournalNo=U0095A") }}
JST classification (1):
JST classification
Category name(code) classified by JST.
Drug therapy(=pharmacotherapy)for mental disorders 
Substance index (1):
Substance index
Chemical Substance indexed to the Article.
Reference (28):
  • Akkaya, C., E. Y. Sivrioglu, S. Akroz, and S. S. Eker.2006. Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: An open study. Human Psychopharmacology Clinical Exp 21:337-345.
  • Andreoli, V., V. Caillard, R. S. Deo, J. K. Rybakowski, and M. Versiani.2002. Reboxetine, a new noradrenaline selective antidepressant, is at least as effective as fluoxetine in the treatment of depression. Journal of Clinical psychopharmacology 22:393-399.
  • Ban, T. A., P. Gaszner, E. Aguglia, R. Batista, A. Castillo, A. Lipcsey, and J.-P. Marcher.1998. Clinical efficacy of Reboxetine: a comparative study with desipramine, with Methodological considerations. Human Psychopharmacology 13:S29-S39.
  • Berzewski, H., M. Van Moffaert, and C. A. Gagiano.1997. Efficacy and tolerability of reboxetine with imipramine in a double-blind study in patients suffering from major depressive episodes. European Neuropsychopharmacology 7:S37-S47.
  • Clayton, A. H., J. Zajecka, J. M. Ferguson, J. K. Filipiak-Reisner, M. T. Brown, and G. E. Schwartz.2003. Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder. International Clinical Psychopharmacology 18:151-156.
more...

Return to Previous Page